Please login to the form below

Not currently logged in
Email:
Password:

binge eating disorder

This page shows the latest binge eating disorder news and features for those working in and with pharma, biotech and healthcare.

Shire pitching at adult ADHD product launch in 2017

Shire pitching at adult ADHD product launch in 2017

The FDA has agreed a regulatory route for Shire's attention deficit hyperactivity disorder (ADHD) product for adults, potentially opening up a lucrative new market for the company's franchis e. ... Breaking into the adult ADHD - as well as a sideways

Latest news

  • Monica Seles to front Shire’s binge eating disorder campaign Monica Seles to front Shire’s binge eating disorder campaign

    Seles recently admitted to experiencing binge eating disorder when she was a professional tennis player in the 1990s. “ ... There is a misconception that adults with binge eating disorder fit a certain profile,” said Seles. “

  • Shire gets FDA nod for first binge-eating treatment Shire gets FDA nod for first binge-eating treatment

    Shire's big-selling Vyvanse brand has become the first drug approved in the US to help people with binge-eating disorder. ... Binge eating disorder is not just about eating a lot; it is that, plus being out of control and feeling bad about it," according

  • Shire to file Vyvanse for binge-eating in Q3 Shire to file Vyvanse for binge-eating in Q3

    Shire to file Vyvanse for binge-eating in Q3. Wants to mirror drug’ s success as ADHD treatment. ... Shire wants to achieve with binge-eating disorder what it has achieved with ADHD, helping to legitimise it as a medical condition and building a

  • Shire's ADHD drug fails in depression trial Shire's ADHD drug fails in depression trial

    Shire's ADHD drug fails in depression trial. Company drops Vyvanse for use in major depressive disorder. ... of adults with binge eating disorder.

  • Shire weathers generic Adderall XR challenge Shire weathers generic Adderall XR challenge

    Shire posted revenue growth of 5 per cent for the fourth quarter of 2012 despite facing full generic competition for its attention deficit-hyperactivity disorder (ADHD) drug Adderall XR (amphetamine and ... Russell highlighted developments, such as

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics